XERS· Xeris Biopharma Holdings Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 5 | $368K |
Quarterly ownership history
Last 6 quarters
XERS Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$1.1B
Enterprise value$1.3B
EV / EBITDA (TTM)26.50
P/E ratio (TTM)93.29
Forward P/E19.32
P/S ratio3.58
P/B ratio79.63
PEG ratio—
Cash Flow
Operating cash flow (TTM)$49M
Free cash flow (TTM)$42M
Total cash$112M
Total debt$259M
Debt / equity1987.19
Current ratio2.12
Income Statement
Total revenue (TTM)$315M
Revenue per share (TTM)1.91
Gross profit (TTM)$270M
EBITDA (TTM)$48M
Net income (TTM)$12M
EPS diluted (TTM)0.07
Shares outstanding172,642,055
Float shares163,840,763
Profitability
Gross margin85.89%
Operating margin9.52%
EBITDA margin15.27%
Net margin3.81%
Efficiency
Return on assets (TTM)6.34%
Return on equity (TTM)—
Price History
Current price$6.53
52 Week high$10.08
52 Week low$4.30
50 day average$5.91
200 day average$7.09
Average volume (10 day)1,910,020
1-year beta0.92
1-year price target$11.29
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:43 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com